We have identified in Xenopus and in the mouse two highly related genes, Xiro3 and Irx3 respectively, that encode a Drosophila Iroquois-related homeobox transcription factor. Xiro3 in Xenopus and Irx3 in the mouse are expressed early in the prospective neural plate in a subset of neural precursor cells. In Xenopus, injection of Xiro3 mRNA expands the neural tube and induces ectopic neural tissue in the epidermis, based on the ectopic expression of early neural markers such as Xsox3. In contrast, the differentiation of the early forming primary neurons, as revealed by the expression of the neuronal marker N-tubulin, is prevented by Xiro3 expression. Activation of Xiro3 expression itself requires the combination of a neural inducing (noggin) and a posteriorizing signal (basic fibroblast growth factor). These results suggest that Xiro3 activation constitutes one of the earliest steps in the development of the neural plate and that it functions in the specification of a neural precursor state.
Introduction
During embryonic development, the precursor cells of the vertebrate central nervous system are induced in the dorsal ectoderm by vertical and/or planar signals from a region of the dorsal mesoderm called the organizer (Spemann and Mangold, 1924) . A number of secreted molecules (e.g. noggin, follistatin and chordin) have been identified that are expressed in the organizer and that have neuralizing activity. These factors are thought to act by antagonizing BMP4, which serves as an epidermalizing signal (Lamb et al., 1993; Hemmati-Brivanlou et al., 1994; Sasai et al., 1995; Piccolo et al., 1996; Zimmerman et al., 1996 ; for review, see Bier, 1997) .
By the neural plate stage, the neural ectoderm is patterned in remarkable detail. This is shown by the highly regionalized expression pattern of several genes along the A-P and M-L (prospective D-V axis) of the neural plate (e.g. Kintner, 1993, 1996a,b; Bang et al., 1997) . In addition, in lower vertebrates, a number of neuroectodermal cells exit the cell cycle as early as the neural plate stage and start differentiating (Hartenstein, 1989) . In Xenopus, this is shown by the expression of a neuronal marker, N-tubulin, which is observed in three longitudinal domains on either side of the dorsal midline . Cells that differentiate in these longitudinal domains of the posterior neural plate correspond to the three classes of primary neurons, namely motor neurons, interneurons and sensory neurons, in a medial-to-lateral order. Within these domains of neuronal differentiation, N-tubulin expression is detected in scattered cells among a non-expressing population.
The sequence and molecular nature of the events that follow the initial neuralization of the ectoderm by organizer molecules and which lead to the differentiation of neurons of distinct identities in a precise pattern and temporal order are still poorly understood. As far as A-P patterning is concerned, all neural inducers that are known to date induce neural tissue of anterior character (Lamb et al., 1993; Hemmati-Brivanlou et al., 1994; Sasai et al., 1995) . Therefore, it has been suggested that additional signals from the posterior dorsal axial and non-axial mesoderm are involved in the posteriorization of the induced neural tissue. Recently, it has been reported that anterior neural tissue can be posteriorized by signals such as fibroblast growth factor (FGF), retinoic acid (RA) and Wnt-3A (Cox and Hemmati-Brivanlou, 1995; Kengaku and Okamoto, 1995; Lamb and Harland, 1995; McGrew et al., 1995; Crossley et al., 1996; Papalopulu and Kintner, 1996a; Pownall et al., 1996; Bang et al., 1997; Blumberg et al., 1997) .
As far as the differentiation of primary neurons within the neural ectoderm is concerned, it is thought to be under the control of proneural and neurogenic genes. In Drosophila, proneural genes, which are typically transcription factors of the basic helix-loop-helix (bHLH) class, confer neural potential on groups of ectodermal cells, called proneural clusters (for review, see Campuzano and Modelell, 1992; Ghysen and Dambly-Chaudière, 1993; Skeath and Carroll, 1994; Lewis, 1996) . Subsequently, neurogenic genes, in particular the membrane-bound ligand Delta and the Notch receptor, restrict proneural gene expression to a single cell within each proneural cluster. This cell then becomes a neuroblast (for review, see Campos-Ortega, 1993; Muskavitch, 1994; ArtanavisTsakonas et al., 1995) .
Several transcription factors of the bHLH family have been identified in vertebrates and some appear to be homologues of the Drosophila proneural achaete-scute complex (AS-C) and atonal genes (Guillemot et al., 1993; Zimmerman et al., 1993; Ferreiro et al., 1994; Turner and Weintraub, 1994 ; Lee et al., 1995; Sommer et al., 1995; Ma et al., 1996; Takebayashi et al., 1997) . As mentioned above, in Xenopus, primary neurons form in a scattered pattern within longitudinal domains in the posterior neural plate. Based on expression studies and functional analysis, Xenopus bHLH genes are thought to confer neuronal potential in cells within each longitudinal domain. Thus, these domains have been viewed as analogous to the proneural clusters in Drosophila. In addition, vertebrate homologues of the neurogenic genes Notch and Delta have also been identified (Coffman et al., 1993; Chitnis et al., 1995; Henrique et al., 1995; Simpson, 1995) . Functional studies in Xenopus have shown that, similarly to the Drosophila neurogenic genes, the vertebrate homologues of Notch and Delta have a role in limiting the number of cells that differentiate to neurons within each proneural domain (Coffman et al., 1993; Chitnis et al., 1995) . The expression of neurogenic genes is activated by bHLH transcription factors but, in turn, the expression and/or the activity of certain bHLH transcription factors is restricted by the Notch-Delta inhibitory interactions. This feedback loop between proneural and neurogenic genes is thought to result in the selection of a few cells that differentiate into neurons within each longitudinal proneural domain.
From studies in Xenopus embryos, it has become clear that although all bHLH proneural genes isolated to date can promote neuronal differentiation, they differ in their time and place of expression; in general, genes that are expressed earlier are expressed in a wider domain that encompasses the domain of expression of genes that are expressed later. Furthermore, all the proneural bHLH genes that have been tested have the ability to activate the neurogenic gene Delta, but they differ in their sensitivity to Notch-mediated inhibition. In general, earlier expressed proneural genes (e.g. XASH3 and X-ngnr-1) tend to be more sensitive to inhibition by activated Notch than later expressed genes (e.g. NeuroD) or certain combinations of genes (X-ngnr-1/X-MyT1) (Bellefroid et al., 1996; Chitnis and Kintner, 1996) . Thus, while both early and late bHLH factors convey neuronal potential to cells in which they are expressed, later acting genes or combinations of genes may act to stabilize the process of neuronal differentiation by allowing cells to escape lateral inhibition. In order to emphasize the distinct roles of early and late acting bHLH proneural genes, they have been termed 'neuronal determination' and 'neuronal differentiation' genes, respectively. Additional support for this model is provided by the observation that neuronal determination genes such as X-ngnr-1 have been shown to activate the expression of neuronal differentiation genes such as NeuroD in a unidirectional cascade . These results support the idea that in the developing central nervous system (CNS), cells go through successive stages of specification/commitment, defined by the sequential activation of different sets of transcription factors.
In contrast, very little is known about the events which follow neural induction and precede the selection of neuronal precursor cells. Most vertebrate proneural genes isolated to date are expressed in a punctate manner within the longitudinal domains of the posterior neural plate. One exception is the bHLH gene XASH3, which is uniformly expressed. However, XASH3 expression is restricted to only a small part of the neural plate. Thus, one would 192 predict the existence of additional bHLH proneural genes which are uniformly expressed within the open neural plate and which are responsible for conveying neuronal potential to a large population of neural precursor cells. In addition, one would predict the existence of regulatory genes which are responsible for the site-specific activation of these proneural genes. These regulators of proneural genes would lie downstream of neural induction and they would act before the neuronal potential becomes limited to a few cells by lateral inhibitory interactions. Such genes could be the homologues of the Drosophila homeoboxcontaining Iroquois genes which have been shown to be involved in the site-specific activation of the proneural AS-C genes (Dambly-Chaudière and Leyns, 1992; GomezSkarmeta et al., 1996) and which have therefore been termed prepattern genes.
We now report on the identification of two vertebrate homeobox genes, Xenopus Xiro3 and mouse Irx3, which are homologous to each other and to the Drosophila Iroquois genes. Our analysis of the function of Xiro3 in Xenopus embryos suggests that it functions in the earliest step of neural development to specify a neural precursor state, characterized by the expression of early neural and the absence of neuronal differentiation markers.
Results

Identification of the Xiro3/Irx3 genes
Degenerate primers corresponding to part of the homeodomain of the Drosophila Iroquois genes were used in a PCR to amplify related sequences from a stage 12 Xenopus cDNA library (see Materials and methods). By screening a stage 17 Xenopus cDNA library with the amplified fragment, we have obtained a 1.9 kb cDNA clone, termed Xiro3, which encodes a polypeptide of 448 amino acids containing a homeodomain showing 92% identity to the Drosophila Iroquois homeodomain ( Figure 1A ). In the mouse, three distinct cDNA clones encoding Drosophila Iroquois-related sequences have been isolated (Bosse et al., 1997) . Here, we present one of these clones, named Irx3, that showed 81% identity to Xiro3 in the region upstream of the homeobox and 100% identity within the homeodomain itself ( Figure 1A ). In human, a partial cDNA sequence encoding an identical homeodomain and showing 97% identity in the portion of sequence that precedes the homeobox region has also been reported (HS90308) ( Figure 1B ). Less homology was detected between Xiro3 and the two other murine Irx clones, as well as with other members of the family isolated from Xenopus (Xiro1 and 2) (Gómez-Skarmeta et al., 1998) and from human ( Figure  1B ), arguing that Xiro3 might indeed be the homologue of Irx3. In the region 3Ј to the homeodomain, Irx3 and Xiro3, like all members of the family, have stretches rich in acidic residues that could be involved in transactivation. In addition, two potential phosphorylation sites for mitogen-activated protein kinase (MAPK) (Clark- Lewis et al., 1991; Gonzales et al., 1991) and a short region close to the carboxy-terminus are also conserved (Mc Neill et al., 1997) .
Xiro3 expression pattern in Xenopus embryos
We have analysed Xiro3 expression in Xenopus embryos by in situ hybridization using the entire Xiro3 cDNA clone (Gomez-Skarmeta et al., 1996) ; Mirror (McNeill et al., 1997) . U90304-U90309 are conceptual translations of human partial cDNA sequences.
as probe. Expression of Xiro3 was found primarily in the developing CNS. The first neuroectodermal expression was detected at gastrula stages in two wide bilaterally symmetrical patches within the presumptive neural plate ( Figure 2B and C). During early neurula stages, Xiro3 was expressed in two transverse anterior bands and two short longitudinal stripes, one on either side of the dorsal midline of the embryo ( Figure 2D ). As neurulation proceeds, these longitudinal stripes of expression spread posteriorly in the prospective hindbrain and spinal cord areas ( Figure 2E and F) . Co-hybridization of late neurula embryos with a mixture of Xiro3 and en-2 probes showed that the intense transverse stripes of Xiro3 expression overlapped those of en-2 (data not shown) and were thus located at the midbrain-hindbrain junction. Xiro3 was not expressed in the anterior neural plate, from which the forebrain is derived. Double labelling with Xiro3 and the neuron-specific N-tubulin gene at stage 14 showed that Xiro3 was expressed in both the superficial and deep layers of the neuroectoderm, in regions corresponding to the medial and intermediate stripes of primary neurons ( Figure 2J-L) . Within the deep layer, Xiro3 expression was detected in cells located more superficially than cells expressing the N-tubulin gene ( Figure 2K ). In tadpole stage embryos, Xiro3 expression was detected in the brain, extending well anterior to the midbrain-hindbrain junction but excluding the forebrain, and decreasing in the spinal cord ( Figure 2O ). In cross-sections in the hindbrain region, Xiro3 expression was restricted to an intermediate position along the D-V axis of the neural tube and was localized mainly to the ventricular zone ( Figure 2P ). By contrast, N-tubulin expression at that stage was only detected in the outermost cell layer of the neural tube containing differentiated neurons that do not express Xiro3 (Bellefroid et al., 1996) . Thus, both at neurula and tadpole stages, high levels of Xiro3 expression were observed in undifferentiated neurectodermal cells while lower levels were observed in cells that express N-tubulin.
Compared with the other neural-specific genes, Xiro3 expression appears to be similar to that of the proneural HLH gene XASH3 (Zimmerman et al., 1993) and of the HMG box-encoding gene XSox3 (Koyano et al., 1997; Grainger et al., personal communication) . Like Xiro3, XASH3 is also expressed within the neural plate in the form of two bilaterally symmetrical longitudinal stripes that end in anterior transverse bands ( Figure 2G -I) and it is also expressed in superficial layers of the neurectoderm (data not shown). However, on a side-by-side comparison, we have found that XASH3 was expressed later than Xiro3. For instance, XASH3 expression was not detectable until advanced gastrula stages (stage 11.5-12) while Xiro3 was already detected in the corresponding regions by early gastrulation (stage 11, Figure 2B ). We also found that the anterior transverse bands of Xiro3 expression extended slightly more anterior than those of XASH3 (data not shown). The posterior longitudinal stripes of Xiro3 expression overlap with but are broader than those of XASH3 (compare Figure 2F with Figure 2I ). XSox3, like Xiro3, is also expressed within the posterior neurectoderm in regions excluding the lateral-most area that gives rise to the Rohon-Beard cells, and the XSox3 staining appears to be more superficial than that of N-tubulin ( Figure 2M and N). Thus, both XASH3 and XSox3 appear to be expressed in undifferentiated cells of the neural plate, where Xiro3 is also highly expressed.
In addition to the neural progenitor cells of the posterior nervous system, Xiro3 was also expressed outside of the CNS. At early gastrula stages, Xiro3 was expressed around the closing blastopore in two symmetrical dorsolateral domains ( Figure 2A ). During early to late gastrula stages, Xiro3 was no longer expressed in the circumblastoporal mesoderm but was expressed in the anterior involuted lateral plate mesoderm ( Figure 2K and L, arrows). During late neurula stages, in addition to the staining in the neural plate, weak staining was also detected lateral to the anterior neural plate ( Figure 2F ). In tadpoles ( Figure 2O ), Xiro3 expression was detected in the ectodermal layer of the branchial arches, in the otic vesicle and the kidney.
Expression pattern of Irx3 in the early mouse embryo
In the mouse, the earliest embryonic Irx3 expression was detected at the end of gastrulation, at E7.5 ( Figure 3A ). Saggital sections of embryos at this stage revealed Irx3 transcripts to be restricted to the ectodermal layer, which gives rise to the nervous sytem. In addition, intense staining was detected in the extra-embryonic tissue of the chorionic ectoderm ( Figure 3AЈ ). At E8.0, Irx3 expression is confined to the thickening neural ectoderm corresponding to regions of the future mesencephalon and rhombencephalon ( Figure 3B and BЈ). From E8.5 onwards, Irx3 expression was detected in the prospective midbrain and Figure 3C ). In cross-sections at the level of the hindbrain, Irx3 expression was detected in the ventricular zone of the neural tube, excluding the floor plate and roof plate, and in the cephalic mesenchyme ( Figure 3CЉ ). After closure of the neural tube at E9.5 ( Figure 3D and DЈ), predominant Irx3 expression persisted in the nervous system in the midbrain, hindbrain and spinal cord. Outside of the CNS, Irx3 expression was detectable in the lateral plate mesoderm and the ectodermal layer of the branchial arches. Thus, both in the mouse and in Xenopus, Irx3/Xiro3 is activated at the earliest steps of the development of the CNS and is expressed in neural progenitor cells.
Ectopic expression of Xiro3 in the dorsal ectoderm of the Xenopus embryo causes an increase in neural tissue at the expense of adjacent non-neural tissue
To determine the role of Xiro3 in neural development, we examined the phenotype of embryos that were injected with Xiro3 mRNA. Injection of 0.5-1 ng of Xiro3 mRNA into one cell of the two-cell stage Xenopus embryos results in a failure to gastrulate normally. To circumvent this problem, we directed the expression of Xiro3 into neural 196 tissue and dorsal epidermis by injecting a single dorsal animal pole blastomere of 4 to 32-cell stage embryos with 50-250 pg of Xiro3 RNA. Co-injection of LacZ mRNA served as a lineage marker in order to identify the injected side. In these experiments, overexpression of Xiro3 consistently produced a bulge of tissue on the dorsal side of the embryo (51 out of 57 embryos). When the Xiro3 mRNA was directed to the head region, eye and otic vesicle were reduced or absent. To test for the neural character of this extra tissue, we used a probe for the Xenopus HMG box transcription factor-encoding gene XSox3, a neural marker that is expressed similarly to Xiro3 in the posterior neural plate ( Figure 2M and N) . In situ hybridization analysis of Xiro3-injected embryos with XSox3 showed that the tissue bulge was neural ( Figure 4A ). Ectopic expression of XSox3 could be detected as early as the neural plate stage, not only in the dorsal ectoderm, but also in lateral or ventral regions of the ectoderm that are not contiguous with the CNS (100% of the embryos examined; 25 embryos) ( Figure 4B ). Similar results were obtained using the general neural marker nrp-1 (100% of the embryos examined; 20 embryos) ( Figure 4C ) (Knecht et al., 1995) . In those experiments, the ectopic neural tissue was coincident with the co-injected LacZ RNA in 21 out of 23 embryos examined. Sectioning of these embryos verified the dramatic expansion of the neural tube ( Figure 4D ). Hoechst labelling of nuclei in injected embryos further demonstrated that the cell number on the injected side of the expanded neural tube is strongly increased ( Figure 4E) .
A similar lateral expansion of the neural tube has been observed upon ectopic expression of XASH3 (Ferreiro et al., 1994; Turner and Weintraub, 1994) and of a constitutively active form of X-Notch-1 (Coffman et al., 1993) ; these effects have been attributed mainly to conversion of non-neural cells to a neural fate. To test if this was also true for Xiro3-injected embryos, we looked at the expression of non-neural markers in the injected embryos. The expression of the X-twist gene, a marker of cephalic neural crest cells (Hopwood et al., 1989a) was reduced or absent on the injected side (10 out of 10 embryos tested ( Figure 4F) . Expression of the epidermal keratin gene (Jonas et al., 1985) and the GATA-2 gene (Bertwistle et al., 1996) , which are both expressed in the non-neural ectoderm, was also severely blocked in the injected area of all embryos tested (n ϭ 20 for epidermal keratin and 12 for GATA-2) ( Figure 4G and H) . In addition, in those cases where Xiro3 RNA was directed to mesodermal regions, somite formation was severely impaired, as revealed by the suppression of cardiac actin gene expression ( Figure 4I ). To test if increased cell proliferation also contributes to the expansion of neural tissue, we blocked cell division in Xiro3-injected embryos at mid-gastrula stage with a mixture of hydroxyurea and aphidicolin (HUA) (Harris and Hartenstein, 1991) . Embryos injected with Xiro3 and treated with HUA developed an expanded neural tube just like Xiro3-injected untreated control embryos. Taken together, these results suggest that overexpression of Xiro3 induces extra neural tissue, at least in part by converting adjacent non-neural cells to a neural fate.
Suppression of differentiation of the early forming primary neurons in Xiro3-injected embryos
The data presented so far demonstrate that overexpression of Xiro3 in Xenopus embryos induced ectopic neural tissue, as revealed by the ectopic expression of the neural markers XSox3 and nrp-1. In Xenopus, a number of neuroectodermal cells exit the cell cycle at the neural plate stage to differentiate as primary neurons (Hartenstein, 1989) . To determine the effect of Xiro3 overexpression on the process of primary neuronal differentiation, we examined the expression of the neuronal-specific N-tubulin gene . In Xiro3-injected embryos, N-tubulin was suppressed within the neural plate (25 out of 25 embryos tested) ( Figure 5A ). In 40% of these embryos, we observed a displacement of one or more of the stripes of N-tubulin expression at the border of the Xiro3/lacZ-injected area ( Figure 5B and C) . None of the embryos that were injected outside the neural plate had ectopic N-tubulin expression (19 embryos tested). Similar results were obtained with the X-MyT1 zinc finger gene which is expressed earlier in differentiating primary neurons (Bellefroid et al., 1996) (Figure 5D ).
In contrast, at tadpole stages, when the injected Xiro3 mRNA was most probably degraded, we found that the expanded neural tube was positive for the N-tubulin marker ( Figure 5E) . However, the level of N-tubulin expression was higher in the portion of the neural tube that was weakly stained for X-gal. In addition, when the injected Xiro3 mRNA was directed into the lateral ectoderm, 68 out of 84 embryos examined at the tadpole stage showed bulges in the non-neural ectoderm, 70% of them being N-tubulin positive. As in the expanded neural tube, the N-tubulin staining was localized mainly within the area that stained less intensely with X-gal and therefore most probably contains less of the injected Xiro3 mRNA ( Figure 5F ).
The inhibition of neuronal differentiation we observed in Xiro3-injected embryos might be due to increased lateral inhibition (Chitnis and Kintner, 1996) . Therefore, we looked at the effect of Xiro3 on the expression of X-Delta-1. We found that 63% of the Xiro3-injected embryos show ectopic X-Delta-1 expression (n ϭ 19) ( Figure 5G ). However, co-injection of an antimorphic version of X-Delta-1, called X-Delta-1 stu , which blocks lateral inhibition, did not result in the rescue of the inhibition of N-tubulin expression (n ϭ 68) ( Figure 5H ). In this experiment, control embryos injected with X-Delta-1 stu alone showed an increased in the density of N-tubulinexpressing cells as previously reported (Figure 5I ). These results suggest that Xiro3 prevents the formation of primary neurons and that this inhibition is not the consequence of X-Delta-1 activation of lateral inhibition.
The fact that the effects of Xiro3 on N-tubulin expression were different at early neurula and tadpole stages suggest that the neural tissue induced by Xiro3 was competent to undergo neuronal differentiation but that high levels of Xiro3 expression might be incompatible with neuronal differentiation. To test this idea, we looked at the effect of increased neuronal differentiation on Xiro3 expression. We injected embryos with the X-ngnr-1 neuronal determination gene and asked if it alters the normal expression pattern of Xiro3. As shown in Figure 7A and B, embryos that were injected with X-ngnr-1 showed strong and widespread ectopic N-tubulin expression, as previously described . In contrast, Xiro3 expression was blocked on the injected side of those injected embryos (24/24 embryos examined). Together, these results suggest that a high level of Xiro3 expression promotes an early neural state but that this induced neural tissue is competent to undergo further neuronal diffentiation only when a lower Xiro3 concentration is achieved.
Xiro3 participates in the control of XASH3 expression
As neuronal differentiation is under the control of proneural genes and since in Drosophila, Iroquois genes participate in the positive regulation of AS-C genes, we asked if overexpression of Xiro3 affects proneural gene expression. XASH3 is a putative proneural gene whose expression overlaps with, but appears later than that of Xiro3 (see above). Thus, we tested whether Xiro3 increases expression of XASH3. We found that overexpression of Xiro3 outside the areas where XASH3 is normally expressed did not result in ectopic expression of XASH3 (n ϭ 78). However, when Xiro3 was directed into the neural plate, where XASH3 is normally expressed, we observed that in 21 out of 35 embryos the domain of XASH3 expression was slightly expanded ( Figure 5J ). These results suggest that Xiro3 is involved in the positive regulation of at least some of the proneural genes. The fact that we observed no ectopic expression of XASH3 and in some embryos, only a moderate expansion of XASH3 expression in the neural plate might indicate that additional factors cooperate with Xiro3 to induce proneural gene expression.
Direct activation of early neural gene expression by Xiro3 in animal caps
We have shown that Xiro3 overexpression causes an expansion of the neural tube which is at least partly due to conversion of epidermal tissue into a neural fate (see above). To test this further, we asked if Xiro3 can induce neural tissue in isolated animal caps which, in the absence of additional inducing signals, adopt an epidermal fate. Animal caps were isolated from blastula stage embryos that had been injected bilaterally with Xiro3-encoding RNA, cultured to the equivalent of stage 16, and then assayed for the expression of different marker genes by whole-mount in situ hybridization ( Figure 6 ). As expected, no neural markers were expressed in uninjected animal caps. Injection of Xiro3 mRNA was sufficient to induce the expression of general neural markers such as XSox3, nrp-1 and etr-1. Xiro3 also induced expression of Otx2 which is co-expressed with Xiro3 in the area outside the lateral-anterior neural plate (see Figure 6) . Induction of the above neural markers was also observed when development of the injected caps was stopped at the equivalent of early neurula stage (stage 13) and was found to persist, although at a lower level, after 2 days in culture.
199
These results support the idea that Xiro3 can induce neural tissue in the absence of neural-inducing signals, as opposed to simply enhancing the proliferation of neural tissue.
To test if Xiro3 induced the same type of neural tissue in animal caps as it does in the embryo, we examined the expression of N-tubulin. Consistent with the results in the embryo, N-tubulin was not induced by Xiro3. Another neuronal marker, XIF3 (Sharpe et al., 1989) , was also not induced. To determine if the induction of neural tissue by Xiro3 was a secondary consequence of induction by mesodermal tissue, Xiro3 mRNA-injected animal caps were also analysed for the expression of mesodermal markers. No MyoD and cardiac actin expression was detected. These data indicate that ectopic Xiro3 expression is sufficient to convert animal cap explants directly to an early neural state, characterized by the presence of early neural markers and the absence of neuronal differentiation markers.
Xiro3 expression is induced by a combination of noggin and bFGF
To characterize the inductive signals that initiate Xiro3 expression, we first examined Xiro3 expression in Keller sandwich explants, i.e. in the absence of vertical mesoderm-ectoderm interactions (Keller and Danilchick, 1988) . In these explants (5/5), Xiro3 was expressed in an intense stripe that overlaps with that of en-2 but extends anteriorly, suggesting that it corresponds to the anterior transverse band of Xiro3 expression in whole embryos ( Figure 7C ). Weaker expression was also observed in more posterior neuroectodermal regions that may correspond to expression in the hindbrain and spinal cord. As in whole embryos, expression of Xiro3 was also detected in the cephalic mesendoderm that has migrated away from the neuroectoderm (Doniach et al., 1992) . These results suggested that signals originating from the dorsal mesoderm induce Xiro3 expression and that planar signalling is sufficient to direct correct A-P patterning of its expression.
To examine further the idea that Xiro3 is induced by signals from the organizer, we first tested if Xiro3 is induced by known neural inducers. We observed that noggin was not able to induce Xiro3 expression in animal caps aged to late neurula or tailbud stages ( Figure 7D ). Since Xiro3 is only expressed in the posterior neural plate and noggin only induces anterior neural markers, we reasoned that Xiro3 activation may require a posteriorizing factor. We therefore tested if FGF or RA, two factors which are thought to lead to posteriorization, can induce Xiro3 expression in noggin-treated caps. In these experiments, Xiro3 expression was induced by bFGF, in a stripe near the middle of the elongated tissue ( Figure 7G ). Weak staining was also observed at one end of the elongated structure. No Xiro3 expression was detected in animal caps treated with bFGF alone ( Figure 7F ). In contrast to FGF, RA was not efficient in inducing Xiro3 expression in noggin animal caps ( Figure 7H ) although it was very efficient in suppressing Otx2 expression ( Figure 7E and I) . In elongated caps seen after combined noggin ϩ bFGF treatment, no muscle actin expression was detected, suggesting that Xiro3 induction was not a secondary induction due to mesoderm induction by bFGF (data not shown). To determine if Xiro3 inductive signals require FGF in the whole embryo, a dominant-negative FGF receptor (XFD) was overexpressed. These embryos failed to complete gastrulation due to disruption of mesoderm formation as previously described (Amaya et al., 1991) . Wholemount in situ analysis of the injected embryos shows that XFD did not block the transverse stripe of Xiro3 expression in the midbrain-hindbrain area. This is consistent with previous reports that used other markers for this area of the CNS in XFD-injected embryos (Kroll and Amaya, 1996; Godsave and Durston, 1997) . XFD injection also did not block the more posterior Xiro3 expression, although some embryos showed reduced posterior Xiro3 expression on one side ( Figure 7J ). These observations suggest that the Xiro3-inducing signals can be mimicked by a combination of noggin and FGF, although endogenous FGF may not be directly involved in Xiro3 activation.
Discussion
Xiro3 is expressed uniformly by neural precursors of the posterior CNS
We have shown that Xiro3 is expressed uniformly in a restricted medio-lateral portion of the neural plate that is coincident with XSox3 expression, and that Xiro3 expression overlaps but is wider than that of XASH3. Unlike XSox3, Xiro3 is not expressed in the anterior neural plate and later on in the forebrain, suggesting that the neural programme in the forebrain is distinct from that in the posterior CNS (see Papalopulu and Kintner, 1996a) . The expression of Xiro3 differs from the other known proneural genes in that it is uniform rather than punctate. This punctate pattern of gene expression which precedes the punctate pattern of neuronal differentiation is thought to be generated by the Notch-Delta-mediated inhibitory cell interactions that limit proneural gene expression to a few cells within each longitudinal domain of primary neurons Chitnis and Kintner, 1996; Ma et al., 1996) . We speculate, therefore, that lateral inhibition may not play a central role in regulating Xiro3 expression.
We have found that Xiro3 is expressed in both the deep and superficial cell layers of the neural plate which give rise to the primary and secondary neuronal precursors, respectively (Hartenstein, 1989) . Within the deep layer, cells that express N-tubulin do not appear to express Xiro3 or express it at low levels. Similarly, later on, Xiro3 is expressed mainly in progenitor cells of the ventricular zone whereas N-tubulin is expressed in differentiated cells located in the external-most layer of the neural tube. This early uniform expression of Xiro3 in pluripotent precursors of both primary and secondary neurons and glia suggests that it is an earlier acting gene than all proneural genes identified in vertebrates, including Mash1, neurogenin and NeuroD. These are expressed later in descendant cells and regulate subsequent steps of neurogenesis (Guillemot et al., 1993; Lee et al., 1995; Ma et al., 1996) . Xiro3 expression is induced by noggin plus bFGF but not RA Xiro3 expression starts at gastrula stage in the prospective posterior CNS at around the midbrain-hindbrain region and then spreads posteriorly. This restricted expression suggests that Xiro3 is activated by organizer signals associated with the formation of the posterior CNS. We have found that Xiro3 is induced by noggin and bFGF, a 200 putative posterioring signal. The Xiro3 expression observed in such explants is reminiscent of that in whole embryos and is consistent with the observation that noggin and bFGF generate the anterior-posterior neural pattern in animal caps (Lamb et al., 1995) . Cox and HemmatiBrivanlou (1995) have shown that an interaction between anterior and posterior neural tissue generates tissue of intermediate positional values. Therefore, it is possible that the Xiro3 stripe in the middle of the explant is induced by a secondary interaction of anterior with posterior neural tissue.
Molecules other than bFGF, namely RA and Wnt-3A, have also been reported to have posteriorizing activity. It is not clear how the activities of these molecules differ from each other and how signalling from these diverse pathways is integrated to produce the posterior nervous system. Here we report one difference between two putative posteriorizing signals by showing that Xiro3 is induced by FGF in noggin-neuralized animal caps but is not induced by RA. We have shown previously that RA co-operates with XASH3 to induce neurogenesis in nogginneuralized animal caps (Papalopulu and Kintner, 1996a) . In these experiments, XASH3 was introduced in the animal caps by mRNA injection; therefore, we assume that RA was not able to induce XASH3. Since RA was also unable to induce Xiro3 in noggin-neuralized animal caps (this work), we propose that posterior neuronal differentiation requires RA as well as additional signals that promote the expression of proneural genes. Our findings suggest that one of these signals could be bFGF or a related molecule.
Endogenous FGF is expressed in the posterior of the embryo and is therefore in the right place and time to be inducing Xiro3. However, the role of endogenous FGF in the induction of Xiro3 is not clear since blocking FGF signalling in the whole embryo with a dominant-negative FGF receptor (XFD) does not abolish Xiro3 expression. We note, however, that some XFD-injected embryos express Xiro3 at a reduced level in posterior regions. One possibility is that endogenous FGF may be involved in Xiro3 activation but there are inputs by other signalling pathways that allow some Xiro3 expression in the absence of FGF signalling. In any case, it seems likely that Xiro3 is regulated at multiple levels. We note, for example, that the Xiro3 protein contains MAPK phosphorylation sites, suggesting that not only the expression but also the activity of the Xiro3 protein could be regulated by bFGF or a related tyrosine kinase.
Finally, although the nature of the endogenous Xiro3-inducing signals remains unclear, we have shown that they can act within the plane of the ectoderm. Thus, planar signals that act over an extended range, either by diffusion or a relay mechanism, are sufficient to induce a range of genes that mark position along the A-P axis (Doniach et al., 1992; Papalopulu and Kintner, 1993; Blitz and Cho, 1995) , neural specification (this work) and neuronal differentiation (Sater et al., 1993) .
Xiro3 induces neural tissue de novo
When ectopically expressed in embryos, Xiro3 leads to a dramatic enlargement of the neural tube. This enlargement appears to be due at least in part to conversion of surrounding non-neural tissue to a neural fate. Several findings support the idea that Xiro3 can induce neural tissue de novo. First, blocking cell division in midgastrulation does not eliminate the enlarged neural tube phenotype. Second, when the RNA is directed to lateral and ventral regions of the embryo, neural tissue forms non-contiguously with the host neural plate. Third, neural crest and epidermal markers are suppressed over that affected area and, finally, Xiro3 can induce neural tissue in isolated animal caps.
Xiro3 expression prevents the differentiation of the early forming primary neurons
In contrast to the ectopic expression of XSox3 and other early neural markers, neuronal differentiation markers such as N-tubulin are not induced within the epidermis of neurula embryos in response to Xiro3 overexpression. Furthermore, we have shown that the expression of N-tubulin is down-regulated when Xiro3 mRNA is injected into cells located inside the neural plate. These results differ from findings obtained with the bHLH genes that have proneural activities. Overexpression of NeuroD or XATH3 induces the ectopic expression of both early neural specification markers and neuronal differentiation markers (Lee et al., 1995; Ma et al., 1996) . Another bHLH gene, XATH1, can only induce ectopic expression of neuronal differentiation markers (Kim et al., 1997) . Thus, Xiro3 appears to be unique compared with the known Xenopus proneural genes, in that it induces only some early neural fate.
Why do high levels of Xiro3 induce an early neural state and prevent the completion of neuronal differentiation? We have shown that a high level of Xiro3 expression blocks the expression of neuronal regulatory factors such as X-MyT1. We have also observed that overexpression of Xiro3 induces ectopic X-Delta-1 expression, suggesting the lack and/or suppression of neuronal differentiation might be due to X-Delta-1 activation of lateral inhibition . However, co-injection of X-Delta-1 stu , an antimorphic form of X-Delta-1, showed that this is not the case.
One interpretation of the lack of neuronal differentiation in Xiro3-expressing tissue is that additional factors are needed. These missing factors may be indepedent of Xiro3 and act in parrallel with it. Alternatively, they may be linearly downstream of Xiro3 but their expression and/or activity may be prevented by the elevated expression of Xiro3. A number of observations favour this second possibility. First, the effects of Xiro3 on N-tubulin expression were stage dependent such that N-tubulin expression was detected in later stage embryos. Since the levels of the injected RNA and resulting protein decline during development, we speculate that the differentiation programme is initiated by Xiro3 but is not completed until the levels of Xiro3 decline. Second, there is an inverse correlation between Xiro3 expression on one hand and N-tubulin on the other. Embryos with increased Xiro3 expression do not express N-tubulin, and inversely, embryos with increased, ectopic and premature N-tubulin expression (caused by X-ngnr-1 overexpression) do not express Xiro3. Finally, we have shown that in the embryo, neural precursors express high levels of Xiro3 while differentiated neurons do not express Xiro3 or express it at lower levels. Thus, cells that express high levels of Xiro3 appear not to differentiate and, inversely, cells that 201 differentiate do not express high levels of Xiro3. According to this model, high levels of Xiro3 expression are incompatible with neuronal differentiation; the neural programme is initiated by Xiro3 but Xiro3 expression and/or activity must be down-regulated in order for the neural programme to be completed. It is not clear how cells turn off Xiro3 expression in order to differentiate. Our results suggest that cells that express high levels of X-ngnr1 turn off Xiro3, so X-ngnr1 could be involved directly in downregulating Xiro3 expression.
Does Xiro3 induce proneural gene expression?
One of the functions of the Drosophila genes of the Iroquois complex is to activate proneural gene expression. Does the Xenopus Xiro3 gene perform a similar function? We have shown that Xiro3 expression precedes and overlaps extensively with that of XASH3 and that Xiro3 injections into the embryo result in moderate up-regulation of XASH3. Additionally, Xiro3 overexpression gives embryos with an expanded neural tube, a phenotype also observed after XASH3 overexpression (Fereirro et al., 1994; Turner et al., 1994) . These results suggest that Xiro3 may act upstream of XASH3. However, the observations that XASH3 expression is only moderately expanded within the neural plate of Xiro3-injected embryos and that it is not induced in Xiro3-injected animal caps (unpublished observations) suggest that factors additional to Xiro3 might be required to fully activate XASH3 expression, perhaps on a co-operative basis.
Additional but indirect evidence that Xiro3 regulates positively the expression and/or function of other proneural bHLH genes is provided by several observations. First, overexpression of CASH4 and XATH3 in Xenopus embryos produces a neural tube enlargement similar to that produced by Xiro3 (Henrique et al., 1997; Takebayashi et al., 1997) . The same phenotype has been also observed after overexpression of an activated from of the X-Notch-1 receptor (Coffman et al., 1993) which may be due to a proneural function of X-Notch-1 early in development, as has been described recently in Drosophila (Baker and Yu, 1997) . Second, proneural genes have been shown to induce the expression of X-Delta-1 . Therefore, the ectopic expression of X-Delta-1 in Xiro3-injected embryos is compatible with the idea that Xiro3 induces proneural gene expression which subsequently induces the expression of X-Delta-1. It remains to be seen more directly whether Xiro3 activates the expression of proneural genes such as X-ngnr-1 , XATH3 (Takebayashi et al., 1997) or the homologue of the chicken gene CASH4 (Henrique et al., 1997) , which has not been isolated from Xenopus yet. The Xenopus homologue of the HMG transcription factor XSox3 is also one of the putative targets of Xiro3 since it is expressed in a very similar pattern in the posterior neural plate and it is induced by Xiro3 overexpression. Although XSox3 has been hypothesized to have a role in neural competence (Rex et al., 1997) , functional studies in Xenopus or mice are needed to establish its role in neural development. We assume that additional proneural genes exist that could be targets of Xiro3 and that these will be found in the future.
In conclusion, we have shown that Xiro3 is expressed in undifferentiated neural precursor cells in the posterior CNS before neural differentiation begins and that it can induce an early neural fate. Furthermore, its expression is induced by a combination of noggin, a neural-inducing signal, and bFGF, a posteriorizing signal. We therefore suggest that Xiro3 is one of the earliest genes acting in the genetic cascade that leads to neurogenesis; we suggest that Xiro3 is downstream of neural induction but upstream of neuronal differentiation and that it functions in specifying neural precursors. These primers were used for PCR (94°C for 1 min, 56°C for 1 min, 72°C for 1 min, 35 cycles) using as template cDNA from a stage 12 library in pcDNA1 (provided by Dr N.Garret). A 150 bp fragment was obtained, cloned in pGEM-T and sequenced. The PCR product was then used as probe to screen 10 6 phages from a stage 17 Xenopus embryo cDNA library in λgt10 (Kintner and Melton, 1987) . Six positive clones were isolated, out of which five were identical to each other as judged from their restriction pattern. The longest of these clones was sequenced and termed Xiro3. The Xiro3 sequence has been deposited in DDBJ/ EMBL/GenBank (accession No. AF027175)
Materials and methods
Isolation of Xiro3 cDNA
In situ hybridization of mouse embryos Whole-mount in situ hybridizations were performed as described (Wilkinson, 1992 ) using digoxigenin-labelled antisense RNAs corresponding to the 0.6 kb EcoRV-SmaI fragment of mouse Irx3 cDNA.
RNA injection and in situ hybridization of Xenopus embryos
The entire Xiro3 coding region was subcloned into the pCS2ϩ vector (Turner and Weintraub, 1994) . After linearization with NotI, the vector was transcribed in vitro with SP6 polymerase in the presence of GpppG to produce capped Xiro3 transcripts. Xiro3 RNA (100-250 pg) along with 20 pg of LacZ RNA was injected in a volume of 10 nl into a single blastomere of 2-to 32-cell stage Xenopus embryos. As a negative control, embryos were similarly injected with LacZ RNA alone. X-ngnr-1 (0.5 ng; Ma et al., 1996) RNAs were prepared as originally described and injected in the animal region at the two-cell stage in only one blastomere. XFD (1.0 ng; Amaya et al., 1991) and noggin (0.5 ng; Lamb et al., 1993) mRNAs were injected into each of the blastomeres at the two-cell stage embryo. At various stages, the injected embryos were fixed, stained with X-gal to reveal the distribution of the LacZ tracer, and then analysed by whole-mount in situ hybridization as described (Bellefroid et al., 1996) . Antisense RNA probes from N-tubulin , X-MytT1 (Bellefroid et al., 1996) , X-Delta-1 , X-twist (Hopwood et al., 1989a) , MyoD (Hopwood et al., 1989b) , Otx2 (Pannese et al., 1995) , etr-1 (Knecht et al., 1995) , XASH3 Weintraub, 1994), engrailed-2 (HemmatiBrivanlou et al., 1991) , XSox3 (kindly provided by Dr R.M.Grainger), cardiac actin (Mohun et al., 1984) , XIF3 (Sharpe et al., 1989) , nrp-1 (Knecht et al., 1995) , GATA-2 (Bertwistle et al., 1996) and epidermal keratin (Jonas et al., 1985) were transcribed with digoxigenin or fluorescein as previously described. For double in situ hybridization, probes were visualized sequentially with the corresponding specific alkaline phosphatase conjugates using first Fast Red (Boehringer) or BCIP alone for the fluorescein-labelled probe and then NBT/BCIP or Magenta phos (Molecular Probes Europe) for the second digoxigeninlabelled probe.
Embryos, animal cap explants, HUA, FGF and RA treatment Embryos were obtained from Xenopus laevis adult frogs by hormoneinduced egg laying and in vitro fertilization using standard methods. Animal caps were dissected from stage 9-10 embryos and cultured in 1ϫ MBSH ϩ 0.1% bovine serum albumin. For RA treatment, caps were treated with 2ϫ10 -6 M RA in dimethylsulfoxide. For FGF treatment, caps were incubated in the presence of 100 ng/ml bFGF. Animal caps were cultured until neurula or tailbud stages and fixed for in situ hybridization. To block cell division, embryos at stage 11 were maintained 202 in 20 mM hydroxyurea and 150 μM aphidicolin as previously described (Harris and Hartenstein, 1991) .
